HOLLY CLARK: Open Payments
NPI 1205823093 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 43 payments from 16 companies in 2025. Trend: 2023 $2,315 · 2024 $1,676 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $274 |
| ABBVIE INC. | 4 | $251 |
| Lilly USA, LLC | 7 | $212 |
| Exact Sciences Corporation | 4 | $161 |
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| Phathom Pharmaceuticals, Inc. | 2 | $119 |
| Aimmune Therapeutics, Inc. | 1 | $119 |
| Gilead Sciences, Inc. | 1 | $118 |
| Madrigal Pharmaceuticals | 1 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
Products named: Ozempic, The Cologuard Plus Collection Kit, LINZESS, VOQUEZNA, ZENPEP, Epclusa, BREZTRI, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
